The Venture Codex Logo

The Venture Codex

AstraZeneca

1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, Cambridgeshire, CB2 0AA, United Kingdom

Overview

Biopharmaceutical company developing innovative prescription medicines.

Founded

1999

Deals · 12mo

4

Links

WebsiteLinkedInX (Twitter)

Stage focus

Series B

Geographic focus

China
Israel
Switzerland
United Kingdom
...

Sector focus

Biopharma
Biotechnology
Health Care
Medical
...

Investment portfolio

25rounds
NAMEDATESIZE
Multiply Labs
Oct 2026Participated
$75 MSeries B
Syneron Bio
Apr 2026Participated
$150 MSeries B
Syneron Bio
Dec 2025Participated
$100 MSeries A
Cassidy Bio
Nov 2025Participated
$8 MSeed
Promise Bio
Oct 2024Participated
$8 MSeed
Mintify
Aug 2024Participated
$3 MOther Equity
Huma
Jul 2024Participated
$80 MSeries D
SmartCella
Jul 2024Led
$54 MOther Equity
Cellectis
May 2024Led
$140 MOther Equity
Asher Bio
Apr 2024Participated
$55 MSeries C
Lore
Apr 2023Participated
$4 MOther Equity
Huma
Mar 2022Led
$33 MOther Equity
Multiply Labs
Oct 2026Participated
$75 MSeries B
Syneron Bio
Apr 2026Participated
$150 MSeries B
Syneron Bio
Dec 2025Participated
$100 MSeries A
Cassidy Bio
Nov 2025Participated
$8 MSeed
Promise Bio
Oct 2024Participated
$8 MSeed
Mintify
Aug 2024Participated
$3 MOther Equity
Huma
Jul 2024Participated
$80 MSeries D
SmartCella
Jul 2024Led
$54 MOther Equity
Cellectis
May 2024Led
$140 MOther Equity
Asher Bio
Apr 2024Participated
$55 MSeries C
Lore
Apr 2023Participated
$4 MOther Equity
Huma
Mar 2022Led
$33 MOther Equity
25
Items
...
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

AstraZeneca: 25 funding rounds are recorded in the selected participation categories.All available history.
AstraZeneca: 25 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Seed02
Series A01
Series B13
Series C+14
Other Equity58

Monthly Deal Activity

AstraZeneca: 25 deals are recorded across 142 months.All available history.
AstraZeneca: 25 deals are recorded across 142 months. All available history
MonthDeals
Jan '151
Feb '150
Mar '151
Apr '150
May '150
Jun '150
Jul '150
Aug '150
Sep '151
Oct '150
Nov '150
Dec '150
Jan '160
Feb '160
Mar '160
Apr '161
May '160
Jun '160
Jul '160
Aug '161
Sep '160
Oct '161
Nov '160
Dec '160
Jan '171
Feb '170
Mar '170
Apr '170
May '170
Jun '170
Jul '170
Aug '170
Sep '171
Oct '171
Nov '171
Dec '170
Jan '180
Feb '181
Mar '180
Apr '180
May '180
Jun '180
Jul '180
Aug '180
Sep '181
Oct '180
Nov '180
Dec '180
Jan '190
Feb '190
Mar '190
Apr '190
May '190
Jun '190
Jul '190
Aug '190
Sep '190
Oct '190
Nov '190
Dec '190
Jan '200
Feb '200
Mar '200
Apr '200
May '200
Jun '200
Jul '200
Aug '200
Sep '200
Oct '200
Nov '200
Dec '200
Jan '210
Feb '210
Mar '210
Apr '210
May '210
Jun '210
Jul '210
Aug '210
Sep '210
Oct '210
Nov '211
Dec '210
Jan '220
Feb '220
Mar '221
Apr '220
May '220
Jun '220
Jul '220
Aug '220
Sep '220
Oct '220
Nov '220
Dec '220
Jan '230
Feb '230
Mar '230
Apr '231
May '230
Jun '230
Jul '230
Aug '230
Sep '230
Oct '230
Nov '230
Dec '230
Jan '240
Feb '240
Mar '240
Apr '241
May '241
Jun '240
Jul '242
Aug '241
Sep '240
Oct '241
Nov '240
Dec '240
Jan '250
Feb '250
Mar '250
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '250
Oct '250
Nov '251
Dec '251
Jan '260
Feb '260
Mar '260
Apr '261
May '260
Jun '260
Jul '260
Aug '260
Sep '260
Oct '261

Sector Breakdown

AstraZeneca: Health & Life Sciences is the largest displayed sector by deal count (23 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

AstraZeneca: Health & Life Sciences is the largest displayed sector by deal count (23 deals). All available history
SectorDeals
Health & Life Sciences23
AI & Machine Learning6
Crypto & Blockchain2
Enterprise Software2
Hardware & Robotics1
Fintech1
Manufacturing1
Space & Frontier Tech1
Social & Community Platforms1

Deal Size Distribution

AstraZeneca: 25 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

AstraZeneca: 25 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M2
$5M-$10M2
$10M-$25M3
$25M-$50M4
$50M-$100M7
$100M-$250M6
$250M-$500M1
$500M-$1B0
$1B+0

Deals By Geography

AstraZeneca: United States has the largest recorded deal count among the displayed regions (13 deals).All available history.

Top 4 of 4 regions; European countries are grouped as Europe.

AstraZeneca: United States has the largest recorded deal count among the displayed regions (13 deals). All available history
RegionDeals
United States13
Europe7
China3
Israel2
AstraZeneca: 20 co-investors are shown, with Fletcher Spaght Ventures sharing 4 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

AstraZeneca: 20 co-investors are shown, with Fletcher Spaght Ventures sharing 4 recorded deals. All available history
Co-investorShared deals
Fletcher Spaght Ventures4
Hatteras Venture Partners4
Johnson & Johnson Innovation4
New Enterprise Associates4
Auven Therapeutics3
Syno Capital3
5Y Capital2
GL Ventures2
Google Ventures2
Lenovo Capital2
Novartis2
Pfizer2
RA Capital Management2
Wellington Management2
Wild Family Office2
10D1
Ahren Innovation Capital1
Alexion Pharmaceuticals1
AMF1
Arca1

Investment Strategy

AstraZeneca: Led accounts for 28% and participating for 72% of round participation.All available history.
AstraZeneca: Led accounts for 28% and participating for 72% of round participation. All available history
CategoryDeals (count)Share (%)
Led728%
Participating1872%
AstraZeneca: Single-lead accounts for 86% and co-led for 14% of lead dynamics.All available history.
AstraZeneca: Single-lead accounts for 86% and co-led for 14% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead686%
Co-led114%

Team

Bonnie Cheuk

Senior Business and Digital Transformation Leader

Carl Sidenvall

Project Manager

Jenny Leo

Vice President Human Resources China

Karan Arora

Head, Commercial Digital & Innovation, Global Vice President

Laura Bonifacio

Senior Global Clinical Operations Program Director

Michel Vandenberghe

Director

Nicholas Darton

Principal Scientist

Sofía Calderón Flores

Procurement Team Manager